

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sphingosine metabolic process (GO:0006670) | 8.93554107 |
| 2 | diol metabolic process (GO:0034311) | 8.39089668 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.43377212 |
| 4 | sphingoid metabolic process (GO:0046519) | 6.87947194 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 6.03767218 |
| 6 | protein localization to kinetochore (GO:0034501) | 5.85532471 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.62683451 |
| 8 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.50556356 |
| 9 | lipopolysaccharide biosynthetic process (GO:0009103) | 5.35609810 |
| 10 | rRNA transcription (GO:0009303) | 5.31548365 |
| 11 | negative regulation of epidermis development (GO:0045683) | 5.31150818 |
| 12 | somite rostral/caudal axis specification (GO:0032525) | 5.22811295 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.12200026 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 5.12200026 |
| 15 | regulation of response to osmotic stress (GO:0047484) | 5.10520278 |
| 16 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.97248814 |
| 17 | lipopolysaccharide metabolic process (GO:0008653) | 4.91843999 |
| 18 | DNA methylation involved in gamete generation (GO:0043046) | 4.90113702 |
| 19 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.81073454 |
| 20 | negative regulation of telomerase activity (GO:0051974) | 4.70628778 |
| 21 | quinone metabolic process (GO:1901661) | 4.70578645 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 4.69944604 |
| 23 | rRNA methylation (GO:0031167) | 4.69253049 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.64749776 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 4.64749776 |
| 26 | regulation of cilium movement (GO:0003352) | 4.60317860 |
| 27 | rRNA modification (GO:0000154) | 4.58315729 |
| 28 | histone H4-K5 acetylation (GO:0043981) | 4.53391529 |
| 29 | histone H4-K8 acetylation (GO:0043982) | 4.53391529 |
| 30 | cytidine deamination (GO:0009972) | 4.51213466 |
| 31 | cytidine metabolic process (GO:0046087) | 4.51213466 |
| 32 | cytidine catabolic process (GO:0006216) | 4.51213466 |
| 33 | mitotic sister chromatid segregation (GO:0000070) | 4.47986615 |
| 34 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.41608388 |
| 35 | regulation of translation in response to stress (GO:0043555) | 4.41151868 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 4.40906878 |
| 37 | protein localization to chromosome, centromeric region (GO:0071459) | 4.36237343 |
| 38 | coenzyme catabolic process (GO:0009109) | 4.35627347 |
| 39 | cullin deneddylation (GO:0010388) | 4.35206836 |
| 40 | DNA replication checkpoint (GO:0000076) | 4.34669888 |
| 41 | protein retention in ER lumen (GO:0006621) | 4.32569138 |
| 42 | muscle organ morphogenesis (GO:0048644) | 4.31195010 |
| 43 | histone H4-K12 acetylation (GO:0043983) | 4.30714252 |
| 44 | interferon-gamma production (GO:0032609) | 4.26728881 |
| 45 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.25006530 |
| 46 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.20573576 |
| 47 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.18989463 |
| 48 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.16316410 |
| 49 | protein deneddylation (GO:0000338) | 4.14665925 |
| 50 | nucleoside transmembrane transport (GO:1901642) | 4.14534678 |
| 51 | pseudouridine synthesis (GO:0001522) | 4.10868494 |
| 52 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.08347819 |
| 53 | ribosomal small subunit biogenesis (GO:0042274) | 4.06284201 |
| 54 | formation of translation preinitiation complex (GO:0001731) | 4.05381964 |
| 55 | negative regulation of telomere maintenance (GO:0032205) | 4.02799062 |
| 56 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.93119784 |
| 57 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.90822984 |
| 58 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.90822984 |
| 59 | primitive streak formation (GO:0090009) | 3.86446929 |
| 60 | DNA damage response, detection of DNA damage (GO:0042769) | 3.80660942 |
| 61 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.79909278 |
| 62 | sister chromatid segregation (GO:0000819) | 3.72480905 |
| 63 | ribosome biogenesis (GO:0042254) | 3.71750085 |
| 64 | phenol-containing compound catabolic process (GO:0019336) | 3.70081830 |
| 65 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65857695 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65857695 |
| 67 | hormone catabolic process (GO:0042447) | 3.63893228 |
| 68 | response to dietary excess (GO:0002021) | 3.60143389 |
| 69 | maintenance of protein localization in organelle (GO:0072595) | 3.59146029 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.57145277 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.57145277 |
| 72 | mannose metabolic process (GO:0006013) | 3.54112411 |
| 73 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.51048205 |
| 74 | germinal center formation (GO:0002467) | 3.45733670 |
| 75 | piRNA metabolic process (GO:0034587) | 3.44774532 |
| 76 | heterochromatin organization (GO:0070828) | 3.44278986 |
| 77 | transcription from mitochondrial promoter (GO:0006390) | 3.44028095 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.42905033 |
| 79 | mitochondrial DNA replication (GO:0006264) | 3.42323079 |
| 80 | protein-chromophore linkage (GO:0018298) | 3.41837806 |
| 81 | DNA unwinding involved in DNA replication (GO:0006268) | 3.38051947 |
| 82 | regulation of telomerase activity (GO:0051972) | 3.34855631 |
| 83 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.32106990 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 3.27826976 |
| 85 | sulfate transmembrane transport (GO:1902358) | 3.27068164 |
| 86 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25999343 |
| 87 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.23356471 |
| 88 | response to thyroid hormone (GO:0097066) | 3.22856423 |
| 89 | mitochondrion distribution (GO:0048311) | 3.22192420 |
| 90 | histone H4-K16 acetylation (GO:0043984) | 3.20915007 |
| 91 | regulation of superoxide anion generation (GO:0032928) | 3.20196061 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15535389 |
| 93 | positive regulation of protein deacetylation (GO:0090312) | 3.10378200 |
| 94 | protein maturation by protein folding (GO:0022417) | 3.09889613 |
| 95 | proline biosynthetic process (GO:0006561) | 3.09221882 |
| 96 | chromatin assembly (GO:0031497) | 3.06752887 |
| 97 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.04613766 |
| 98 | protein polyglutamylation (GO:0018095) | 3.03599139 |
| 99 | primary alcohol catabolic process (GO:0034310) | 3.01891046 |
| 100 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.01313619 |
| 101 | regulation of microtubule-based movement (GO:0060632) | 2.96707343 |
| 102 | apoptotic DNA fragmentation (GO:0006309) | 2.96366457 |
| 103 | DNA replication initiation (GO:0006270) | 2.94835350 |
| 104 | nucleoside transport (GO:0015858) | 2.94192717 |
| 105 | cofactor transport (GO:0051181) | 2.94126665 |
| 106 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.93933681 |
| 107 | mitotic chromosome condensation (GO:0007076) | 2.93489691 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 2.92708565 |
| 109 | glycolipid catabolic process (GO:0019377) | 2.91714336 |
| 110 | activation of Rac GTPase activity (GO:0032863) | 2.91549747 |
| 111 | flavonoid metabolic process (GO:0009812) | 2.91047699 |
| 112 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.88143095 |
| 113 | cellular component biogenesis (GO:0044085) | 2.87451342 |
| 114 | microtubule severing (GO:0051013) | 2.87162655 |
| 115 | tyrosine metabolic process (GO:0006570) | 2.86319464 |
| 116 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.84911731 |
| 117 | DNA duplex unwinding (GO:0032508) | 2.82730754 |
| 118 | negative regulation of interleukin-2 production (GO:0032703) | 2.80884293 |
| 119 | heme transport (GO:0015886) | 2.79859200 |
| 120 | notochord development (GO:0030903) | 2.79633333 |
| 121 | * negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.79313488 |
| 122 | DNA geometric change (GO:0032392) | 2.77892927 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 2.77566108 |
| 124 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.77146373 |
| 125 | cardiovascular system development (GO:0072358) | 2.76697767 |
| 126 | regulation of ARF GTPase activity (GO:0032312) | 2.75753597 |
| 127 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.73585422 |
| 128 | regulation of telomere maintenance (GO:0032204) | 2.73422029 |
| 129 | cofactor catabolic process (GO:0051187) | 2.72078327 |
| 130 | nuclear pore complex assembly (GO:0051292) | 2.71076285 |
| 131 | amyloid precursor protein catabolic process (GO:0042987) | 2.70452160 |
| 132 | * negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.70255542 |
| 133 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.69210099 |
| 134 | maternal placenta development (GO:0001893) | 2.69089555 |
| 135 | epoxygenase P450 pathway (GO:0019373) | 2.67736352 |
| 136 | sulfate transport (GO:0008272) | 2.67237316 |
| 137 | retinoic acid receptor signaling pathway (GO:0048384) | 2.66870038 |
| 138 | positive regulation of gluconeogenesis (GO:0045722) | 2.65627480 |
| 139 | mitochondrial DNA metabolic process (GO:0032042) | 2.64813406 |
| 140 | thyroid hormone generation (GO:0006590) | 2.63065078 |
| 141 | pinocytosis (GO:0006907) | 2.63011783 |
| 142 | positive regulation of developmental pigmentation (GO:0048087) | 2.62736554 |
| 143 | protein localization to endosome (GO:0036010) | 2.60946563 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.57765754 |
| 145 | phospholipid efflux (GO:0033700) | 2.57656879 |
| 146 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.56675671 |
| 147 | barbed-end actin filament capping (GO:0051016) | 2.55010687 |
| 148 | glucose 6-phosphate metabolic process (GO:0051156) | 2.54578873 |
| 149 | protein-lipid complex assembly (GO:0065005) | 2.53556737 |
| 150 | ribonucleoprotein complex disassembly (GO:0032988) | 2.52674221 |
| 151 | plasma lipoprotein particle assembly (GO:0034377) | 2.52034229 |
| 152 | galactose metabolic process (GO:0006012) | 2.51882878 |
| 153 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51878619 |
| 154 | regulation of cholesterol esterification (GO:0010872) | 2.46378427 |
| 155 | regulation of triglyceride catabolic process (GO:0010896) | 2.45925201 |
| 156 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.42835767 |
| 157 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.41730708 |
| 158 | ceramide catabolic process (GO:0046514) | 2.41230011 |
| 159 | regulation of necrotic cell death (GO:0010939) | 2.40741100 |
| 160 | modulation by symbiont of host immune response (GO:0052553) | 2.39032770 |
| 161 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39032770 |
| 162 | modulation by symbiont of host defense response (GO:0052031) | 2.39032770 |
| 163 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39032770 |
| 164 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39032770 |
| 165 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39032770 |
| 166 | regulation of necroptotic process (GO:0060544) | 2.38823742 |
| 167 | response to mercury ion (GO:0046689) | 2.37593071 |
| 168 | embryonic process involved in female pregnancy (GO:0060136) | 2.32808734 |
| 169 | SMAD protein complex assembly (GO:0007183) | 2.32102819 |
| 170 | virion assembly (GO:0019068) | 2.31890771 |
| 171 | regulation of extracellular matrix disassembly (GO:0010715) | 2.29797709 |
| 172 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.28929079 |
| 173 | proline metabolic process (GO:0006560) | 2.28380680 |
| 174 | trivalent inorganic anion homeostasis (GO:0072506) | 2.28349627 |
| 175 | phosphate ion homeostasis (GO:0055062) | 2.28349627 |
| 176 | regulation of protein glycosylation (GO:0060049) | 2.27670541 |
| 177 | ncRNA 3-end processing (GO:0043628) | 2.27110661 |
| 178 | negative regulation of stem cell proliferation (GO:2000647) | 2.27028121 |
| 179 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.26419606 |
| 180 | positive regulation of pseudopodium assembly (GO:0031274) | 2.26128462 |
| 181 | amyloid precursor protein metabolic process (GO:0042982) | 2.25498593 |
| 182 | regulation of early endosome to late endosome transport (GO:2000641) | 2.23718174 |
| 183 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.22410582 |
| 184 | regulation of translational termination (GO:0006449) | 2.22167436 |
| 185 | regulation of meiosis I (GO:0060631) | 2.21846711 |
| 186 | urea cycle (GO:0000050) | 2.21016009 |
| 187 | positive regulation of regulated secretory pathway (GO:1903307) | 2.17738564 |
| 188 | regulation of interleukin-5 production (GO:0032674) | 2.16846865 |
| 189 | positive regulation of histone acetylation (GO:0035066) | 2.15854094 |
| 190 | stress fiber assembly (GO:0043149) | 2.15468883 |
| 191 | signal complex assembly (GO:0007172) | 2.13655923 |
| 192 | amino sugar catabolic process (GO:0046348) | 2.11337390 |
| 193 | response to peptidoglycan (GO:0032494) | 2.11101717 |
| 194 | transferrin transport (GO:0033572) | 2.10322109 |
| 195 | daunorubicin metabolic process (GO:0044597) | 11.3079256 |
| 196 | polyketide metabolic process (GO:0030638) | 11.3079256 |
| 197 | doxorubicin metabolic process (GO:0044598) | 11.3079256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.66207362 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.72363689 |
| 3 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.71282784 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.28149989 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.28149989 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.28149989 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.86731161 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80392756 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.72763837 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.62783065 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.62189479 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.60823318 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.33258433 |
| 14 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.32179262 |
| 15 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31635229 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.30825887 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27422687 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.27224517 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.24290904 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22760699 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17919306 |
| 22 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.12997871 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12098411 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10545378 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.08820030 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.05107799 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.05104344 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04049372 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.03285536 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.02351961 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.96492182 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96374082 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92396698 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90374580 |
| 35 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.88078064 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87219027 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.84479786 |
| 38 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.83391328 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.82190759 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79578937 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.76904551 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.75167222 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75111671 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.74672487 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72663032 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71365722 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.66693567 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65503090 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62139915 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.58608464 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57896302 |
| 52 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57665854 |
| 53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56602192 |
| 54 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.56467213 |
| 55 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.55318435 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54299774 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54000562 |
| 58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53787261 |
| 59 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.52976411 |
| 60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52458003 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51826492 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51641979 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51607059 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.51534098 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50720789 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50654477 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.50547799 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49753943 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48561139 |
| 70 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47504741 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46757583 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46217876 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44328582 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42459709 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41573685 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40942435 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40477895 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39081099 |
| 79 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38829762 |
| 80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38458957 |
| 81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37302840 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.37174781 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36941136 |
| 84 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35871741 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35582497 |
| 86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34577801 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33976087 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31480418 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29902784 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28258374 |
| 91 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.28094606 |
| 92 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27540281 |
| 93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27225870 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26360730 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26138427 |
| 96 | MAF_26560356_Chip-Seq_TH2_Human | 1.26033974 |
| 97 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25621393 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24583330 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23658503 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22227762 |
| 101 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.22208882 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21442823 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20958707 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20613813 |
| 105 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20345169 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18971560 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18817826 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.16952131 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15998665 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15818613 |
| 111 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.15746133 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15100417 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15014288 |
| 114 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14507956 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14503135 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14234675 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13934138 |
| 118 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.13323954 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12752526 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12721515 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12357872 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11695880 |
| 123 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10433402 |
| 124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10298293 |
| 125 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.10266161 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10108575 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09659795 |
| 128 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.09648500 |
| 129 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09334375 |
| 130 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09170859 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08665099 |
| 132 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08600907 |
| 133 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07843258 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07838384 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 1.06859877 |
| 136 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.06749097 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06464266 |
| 138 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05425529 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05406332 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04842131 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04731800 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04390585 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03998779 |
| 144 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03910499 |
| 145 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03818194 |
| 146 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02636077 |
| 147 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02106156 |
| 148 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01456050 |
| 149 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01264484 |
| 150 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.01042182 |
| 151 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00351279 |
| 152 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99707724 |
| 153 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99627411 |
| 154 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.98024976 |
| 155 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97440566 |
| 156 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.95332560 |
| 157 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94013485 |
| 158 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.93332934 |
| 159 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93197776 |
| 160 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89835866 |
| 161 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89755977 |
| 162 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89082576 |
| 163 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88171234 |
| 164 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88112023 |
| 165 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.88073393 |
| 166 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87903302 |
| 167 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87431914 |
| 168 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.86615678 |
| 169 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.85766266 |
| 170 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.83170232 |
| 171 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81967169 |
| 172 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.81917625 |
| 173 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.81478368 |
| 174 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80491018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.02611747 |
| 2 | MP0003011_delayed_dark_adaptation | 4.72358961 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.59627045 |
| 4 | MP0006292_abnormal_olfactory_placode | 4.53380055 |
| 5 | MP0005075_abnormal_melanosome_morpholog | 4.46824886 |
| 6 | MP0005058_abnormal_lysosome_morphology | 4.05125551 |
| 7 | MP0009840_abnormal_foam_cell | 3.78337105 |
| 8 | MP0008057_abnormal_DNA_replication | 3.64295344 |
| 9 | MP0005171_absent_coat_pigmentation | 3.63936756 |
| 10 | MP0003136_yellow_coat_color | 3.60895417 |
| 11 | MP0002254_reproductive_system_inflammat | 3.32411954 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 3.20310100 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 3.09912355 |
| 14 | MP0003890_abnormal_embryonic-extraembry | 3.06839302 |
| 15 | MP0008260_abnormal_autophagy | 2.95392625 |
| 16 | MP0003879_abnormal_hair_cell | 2.95010689 |
| 17 | MP0005394_taste/olfaction_phenotype | 2.93480267 |
| 18 | MP0005499_abnormal_olfactory_system | 2.93480267 |
| 19 | MP0003122_maternal_imprinting | 2.91884605 |
| 20 | MP0005451_abnormal_body_composition | 2.62612916 |
| 21 | MP0004858_abnormal_nervous_system | 2.61898392 |
| 22 | MP0003045_fibrosis | 2.58166400 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.57268869 |
| 24 | MP0005365_abnormal_bile_salt | 2.49635464 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.47077439 |
| 26 | MP0002332_abnormal_exercise_endurance | 2.41667310 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.37592481 |
| 28 | MP0003121_genomic_imprinting | 2.22347956 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 2.12816822 |
| 30 | MP0003077_abnormal_cell_cycle | 2.08313852 |
| 31 | MP0003436_decreased_susceptibility_to | 2.04623123 |
| 32 | MP0005360_urolithiasis | 2.01547262 |
| 33 | MP0000678_abnormal_parathyroid_gland | 2.00517974 |
| 34 | MP0003183_abnormal_peptide_metabolism | 2.00257184 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.94264076 |
| 36 | MP0003646_muscle_fatigue | 1.86546677 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.85376811 |
| 38 | MP0005670_abnormal_white_adipose | 1.79273305 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.78153091 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.75233143 |
| 41 | MP0005330_cardiomyopathy | 1.70185018 |
| 42 | MP0005266_abnormal_metabolism | 1.69095402 |
| 43 | MP0006082_CNS_inflammation | 1.63991081 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.62902157 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.62807138 |
| 46 | MP0004233_abnormal_muscle_weight | 1.60622022 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.60394957 |
| 48 | MP0005380_embryogenesis_phenotype | 1.56222689 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.56222689 |
| 50 | MP0006054_spinal_hemorrhage | 1.53199989 |
| 51 | MP0003123_paternal_imprinting | 1.53010812 |
| 52 | MP0002088_abnormal_embryonic_growth/wei | 1.52161446 |
| 53 | MP0003984_embryonic_growth_retardation | 1.51418998 |
| 54 | MP0000490_abnormal_crypts_of | 1.49125549 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.48016290 |
| 56 | MP0003938_abnormal_ear_development | 1.42097469 |
| 57 | MP0002132_abnormal_respiratory_system | 1.39755821 |
| 58 | MP0000350_abnormal_cell_proliferation | 1.38941569 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.38697360 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.37720290 |
| 61 | MP0003111_abnormal_nucleus_morphology | 1.35792254 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.35428172 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.32241279 |
| 64 | MP0005025_abnormal_response_to | 1.32001812 |
| 65 | MP0005387_immune_system_phenotype | 1.30231355 |
| 66 | MP0001790_abnormal_immune_system | 1.30231355 |
| 67 | MP0001293_anophthalmia | 1.28051022 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.27543522 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.26977214 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 1.26855181 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.26512941 |
| 72 | MP0004043_abnormal_pH_regulation | 1.24584341 |
| 73 | MP0008932_abnormal_embryonic_tissue | 1.23715742 |
| 74 | MP0002419_abnormal_innate_immunity | 1.23054688 |
| 75 | MP0004381_abnormal_hair_follicle | 1.22441637 |
| 76 | MP0000313_abnormal_cell_death | 1.21940019 |
| 77 | MP0000858_altered_metastatic_potential | 1.21333782 |
| 78 | MP0000358_abnormal_cell_content/ | 1.19860788 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.17112964 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.15983908 |
| 81 | MP0008961_abnormal_basal_metabolism | 1.14968632 |
| 82 | MP0003186_abnormal_redox_activity | 1.14590739 |
| 83 | MP0001849_ear_inflammation | 1.13757044 |
| 84 | MP0008007_abnormal_cellular_replicative | 1.12122954 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.09790167 |
| 86 | MP0002932_abnormal_joint_morphology | 1.09479226 |
| 87 | MP0002075_abnormal_coat/hair_pigmentati | 1.07833056 |
| 88 | MP0002420_abnormal_adaptive_immunity | 1.07478070 |
| 89 | MP0002723_abnormal_immune_serum | 1.06904900 |
| 90 | MP0001819_abnormal_immune_cell | 1.04445908 |
| 91 | MP0002092_abnormal_eye_morphology | 1.03918937 |
| 92 | MP0002970_abnormal_white_adipose | 1.03789066 |
| 93 | MP0008469_abnormal_protein_level | 1.03506158 |
| 94 | MP0008874_decreased_physiological_sensi | 1.02406407 |
| 95 | MP0002168_other_aberrant_phenotype | 1.00853202 |
| 96 | MP0003329_amyloid_beta_deposits | 0.99247607 |
| 97 | MP0002086_abnormal_extraembryonic_tissu | 0.98997012 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.98569722 |
| 99 | MP0005083_abnormal_biliary_tract | 0.98461745 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.96915058 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.96261378 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.95644580 |
| 103 | MP0000604_amyloidosis | 0.95149045 |
| 104 | MP0003786_premature_aging | 0.94589134 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.94477100 |
| 106 | MP0009278_abnormal_bone_marrow | 0.94151008 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.94123256 |
| 108 | MP0003075_altered_response_to | 0.91309873 |
| 109 | MP0002722_abnormal_immune_system | 0.90053112 |
| 110 | MP0001730_embryonic_growth_arrest | 0.89960974 |
| 111 | MP0009785_altered_susceptibility_to | 0.89328476 |
| 112 | MP0001186_pigmentation_phenotype | 0.89080801 |
| 113 | MP0002085_abnormal_embryonic_tissue | 0.88894016 |
| 114 | MP0008058_abnormal_DNA_repair | 0.86920333 |
| 115 | MP0003705_abnormal_hypodermis_morpholog | 0.86507542 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.85881328 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.85285910 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.85242259 |
| 119 | MP0000049_abnormal_middle_ear | 0.85214225 |
| 120 | MP0002080_prenatal_lethality | 0.85141020 |
| 121 | MP0000749_muscle_degeneration | 0.84631574 |
| 122 | MP0002429_abnormal_blood_cell | 0.84385684 |
| 123 | MP0005501_abnormal_skin_physiology | 0.84215740 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.83933046 |
| 125 | MP0005671_abnormal_response_to | 0.83626455 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.83398138 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.82291260 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81424912 |
| 129 | MP0005409_darkened_coat_color | 0.81301279 |
| 130 | MP0002398_abnormal_bone_marrow | 0.80956744 |
| 131 | MP0010030_abnormal_orbit_morphology | 0.80938369 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.80744623 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.80635976 |
| 134 | MP0003303_peritoneal_inflammation | 0.79127425 |
| 135 | MP0002114_abnormal_axial_skeleton | 0.78945480 |
| 136 | MP0002019_abnormal_tumor_incidence | 0.78641809 |
| 137 | MP0001697_abnormal_embryo_size | 0.78155137 |
| 138 | MP0000685_abnormal_immune_system | 0.77220929 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.74724280 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.74251293 |
| 141 | MP0000762_abnormal_tongue_morphology | 0.73365762 |
| 142 | MP0004147_increased_porphyrin_level | 0.72287747 |
| 143 | MP0004510_myositis | 0.72244727 |
| 144 | MP0001666_abnormal_nutrient_absorption | 0.71266841 |
| 145 | MP0001764_abnormal_homeostasis | 0.71192668 |
| 146 | MP0003866_abnormal_defecation | 0.71037050 |
| 147 | MP0000609_abnormal_liver_physiology | 0.70797725 |
| 148 | MP0008770_decreased_survivor_rate | 0.70049754 |
| 149 | MP0000716_abnormal_immune_system | 0.69324141 |
| 150 | MP0005384_cellular_phenotype | 0.68576776 |
| 151 | MP0003172_abnormal_lysosome_physiology | 0.68377036 |
| 152 | MP0004019_abnormal_vitamin_homeostasis | 0.67962502 |
| 153 | MP0001533_abnormal_skeleton_physiology | 0.67209021 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.67204264 |
| 155 | MP0005391_vision/eye_phenotype | 0.66882968 |
| 156 | MP0002796_impaired_skin_barrier | 0.66678117 |
| 157 | MP0005410_abnormal_fertilization | 0.66404946 |
| 158 | MP0008872_abnormal_physiological_respon | 0.66354438 |
| 159 | MP0009764_decreased_sensitivity_to | 0.65809273 |
| 160 | MP0005397_hematopoietic_system_phenotyp | 0.65515081 |
| 161 | MP0002269_muscular_atrophy | 0.65309508 |
| 162 | MP0002084_abnormal_developmental_patter | 0.63646788 |
| 163 | MP0002233_abnormal_nose_morphology | 0.62183930 |
| 164 | MP0001800_abnormal_humoral_immune | 0.60475303 |
| 165 | MP0004133_heterotaxia | 0.59499366 |
| 166 | MP0000598_abnormal_liver_morphology | 0.58281563 |
| 167 | MP0000703_abnormal_thymus_morphology | 0.57049269 |
| 168 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53751114 |
| 169 | MP0008875_abnormal_xenobiotic_pharmacok | 0.53585216 |
| 170 | MP0003137_abnormal_impulse_conducting | 0.52700518 |
| 171 | MP0000343_altered_response_to | 0.52265213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.83340477 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.76553226 |
| 3 | Multiple enchondromatosis (HP:0005701) | 5.59425091 |
| 4 | Hepatoblastoma (HP:0002884) | 4.85611301 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.53230377 |
| 6 | Amelogenesis imperfecta (HP:0000705) | 4.51890261 |
| 7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.09563596 |
| 8 | Ragged-red muscle fibers (HP:0003200) | 4.08827386 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 4.03551721 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.94357627 |
| 11 | Rib fusion (HP:0000902) | 3.86062788 |
| 12 | Reduced antithrombin III activity (HP:0001976) | 3.84590822 |
| 13 | Ependymoma (HP:0002888) | 3.84037359 |
| 14 | Parakeratosis (HP:0001036) | 3.77771992 |
| 15 | Hypoplasia of the fovea (HP:0007750) | 3.56601989 |
| 16 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.56601989 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.52472404 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 3.43853799 |
| 19 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.42619820 |
| 20 | Partial duplication of thumb phalanx (HP:0009944) | 3.38730231 |
| 21 | Neoplasm of striated muscle (HP:0009728) | 3.31389645 |
| 22 | Rhabdomyosarcoma (HP:0002859) | 3.31076436 |
| 23 | Abnormality of glycolysis (HP:0004366) | 3.24850047 |
| 24 | Increased serum pyruvate (HP:0003542) | 3.24850047 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 3.24722624 |
| 26 | Purpura (HP:0000979) | 3.21575598 |
| 27 | Petechiae (HP:0000967) | 3.20913097 |
| 28 | Type I transferrin isoform profile (HP:0003642) | 3.15208113 |
| 29 | Embryonal renal neoplasm (HP:0011794) | 3.14612146 |
| 30 | Acanthocytosis (HP:0001927) | 3.14256943 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 3.06494798 |
| 32 | Testicular atrophy (HP:0000029) | 3.05841989 |
| 33 | Colitis (HP:0002583) | 3.05768115 |
| 34 | Abnormal lung lobation (HP:0002101) | 3.04911905 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.04538002 |
| 36 | Chromsome breakage (HP:0040012) | 2.99982348 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.99335309 |
| 38 | Bifid tongue (HP:0010297) | 2.99021545 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.98100184 |
| 40 | Trismus (HP:0000211) | 2.97294978 |
| 41 | Loss of speech (HP:0002371) | 2.93951827 |
| 42 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.91602064 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.90925225 |
| 44 | J-shaped sella turcica (HP:0002680) | 2.89027188 |
| 45 | Rectal fistula (HP:0100590) | 2.88692442 |
| 46 | Rectovaginal fistula (HP:0000143) | 2.88692442 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.88248535 |
| 48 | Microretrognathia (HP:0000308) | 2.85799444 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85334504 |
| 50 | Partial duplication of the phalanx of hand (HP:0009999) | 2.83469813 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.83008233 |
| 52 | Abnormality of the fovea (HP:0000493) | 2.81531389 |
| 53 | Abnormal cartilage morphology (HP:0002763) | 2.79605447 |
| 54 | Aplastic anemia (HP:0001915) | 2.79594651 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78389763 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78389763 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78389763 |
| 58 | Anomalous pulmonary venous return (HP:0010772) | 2.75508207 |
| 59 | Achilles tendon contracture (HP:0001771) | 2.71388991 |
| 60 | Tongue fasciculations (HP:0001308) | 2.70290414 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.66962719 |
| 62 | Hyperventilation (HP:0002883) | 2.65781229 |
| 63 | Horizontal nystagmus (HP:0000666) | 2.64477608 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64316626 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.64316626 |
| 66 | Ulnar bowing (HP:0003031) | 2.62741253 |
| 67 | Cholecystitis (HP:0001082) | 2.62712996 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.62712996 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.62459116 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.62126932 |
| 71 | Fused cervical vertebrae (HP:0002949) | 2.59704665 |
| 72 | Intestinal fistula (HP:0100819) | 2.56400978 |
| 73 | Pendular nystagmus (HP:0012043) | 2.56292843 |
| 74 | Hypochromic anemia (HP:0001931) | 2.56034184 |
| 75 | Vaginal fistula (HP:0004320) | 2.54583707 |
| 76 | Meckel diverticulum (HP:0002245) | 2.53957730 |
| 77 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.53111800 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.52751751 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.51377290 |
| 80 | Preauricular skin tag (HP:0000384) | 2.46618078 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.44336447 |
| 82 | Abnormality of the salivary glands (HP:0010286) | 2.44327611 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.42187009 |
| 84 | Nuclear cataract (HP:0100018) | 2.41195694 |
| 85 | Upper limb amyotrophy (HP:0009129) | 2.39254242 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 2.39254242 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.38579537 |
| 88 | Hypokinesia (HP:0002375) | 2.37922175 |
| 89 | Generalized hypotonia (HP:0001290) | 2.37083449 |
| 90 | Astrocytoma (HP:0009592) | 2.36748250 |
| 91 | Abnormality of the astrocytes (HP:0100707) | 2.36748250 |
| 92 | Abnormality of the ileum (HP:0001549) | 2.36537401 |
| 93 | Gastrointestinal stroma tumor (HP:0100723) | 2.35889667 |
| 94 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34906581 |
| 95 | Sensory axonal neuropathy (HP:0003390) | 2.33945131 |
| 96 | Deep venous thrombosis (HP:0002625) | 2.33847789 |
| 97 | Difficulty walking (HP:0002355) | 2.33626239 |
| 98 | Muscle fibrillation (HP:0010546) | 2.33224057 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.30286954 |
| 100 | Rectal prolapse (HP:0002035) | 2.28606760 |
| 101 | Impulsivity (HP:0100710) | 2.28594958 |
| 102 | Fatigue (HP:0012378) | 2.28400320 |
| 103 | Glomerulonephritis (HP:0000099) | 2.28282905 |
| 104 | Abnormality of the pulmonary veins (HP:0011718) | 2.27956543 |
| 105 | Tetraplegia (HP:0002445) | 2.27631353 |
| 106 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.26655967 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24522340 |
| 108 | Eczematoid dermatitis (HP:0000976) | 2.24338216 |
| 109 | Nasolacrimal duct obstruction (HP:0000579) | 2.24260499 |
| 110 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.23738010 |
| 111 | Nasal polyposis (HP:0100582) | 2.22649486 |
| 112 | Opisthotonus (HP:0002179) | 2.20143703 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19281471 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19281471 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19281471 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 2.19270286 |
| 117 | Thoracic kyphosis (HP:0002942) | 2.19164568 |
| 118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.18808672 |
| 119 | Premature ovarian failure (HP:0008209) | 2.17213174 |
| 120 | Inflammation of the large intestine (HP:0002037) | 2.16958665 |
| 121 | Hypertensive crisis (HP:0100735) | 2.15061430 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14778206 |
| 123 | Glossoptosis (HP:0000162) | 2.13112965 |
| 124 | Axonal loss (HP:0003447) | 2.11783896 |
| 125 | Skin tags (HP:0010609) | 2.08384860 |
| 126 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.07361225 |
| 127 | Villous atrophy (HP:0011473) | 2.06373392 |
| 128 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.06373392 |
| 129 | Abnormality of the vocal cords (HP:0008777) | 2.05337088 |
| 130 | Increased serum ferritin (HP:0003281) | 2.04392307 |
| 131 | Amyloidosis (HP:0011034) | 2.04320314 |
| 132 | Progressive external ophthalmoplegia (HP:0000590) | 2.03969833 |
| 133 | Obstructive lung disease (HP:0006536) | 2.03482019 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03482019 |
| 135 | Severe visual impairment (HP:0001141) | 2.02427124 |
| 136 | Hand muscle atrophy (HP:0009130) | 2.02266737 |
| 137 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01667339 |
| 138 | Duodenal stenosis (HP:0100867) | 2.00558642 |
| 139 | Small intestinal stenosis (HP:0012848) | 2.00558642 |
| 140 | Hemorrhage of the eye (HP:0011885) | 2.00022720 |
| 141 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.00010092 |
| 142 | Short 5th finger (HP:0009237) | 1.99770473 |
| 143 | Peripheral hypomyelination (HP:0007182) | 1.99151952 |
| 144 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98247274 |
| 145 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98247274 |
| 146 | Abnormal protein glycosylation (HP:0012346) | 1.98247274 |
| 147 | Abnormal glycosylation (HP:0012345) | 1.98247274 |
| 148 | Myelodysplasia (HP:0002863) | 1.97784055 |
| 149 | Scapular winging (HP:0003691) | 1.95887292 |
| 150 | Fasciculations (HP:0002380) | 1.95007545 |
| 151 | Subcapsular cataract (HP:0000523) | 1.94783301 |
| 152 | Periauricular skin pits (HP:0100277) | 1.94279336 |
| 153 | Preauricular pit (HP:0004467) | 1.94279336 |
| 154 | Cheilitis (HP:0100825) | 1.94213102 |
| 155 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92372107 |
| 156 | Supernumerary spleens (HP:0009799) | 1.92028959 |
| 157 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.91781479 |
| 158 | Facial cleft (HP:0002006) | 1.91512043 |
| 159 | Progressive neurologic deterioration (HP:0002344) | 1.90868874 |
| 160 | Shawl scrotum (HP:0000049) | 1.89471213 |
| 161 | Abnormality of the nasal mucosa (HP:0000433) | 1.88911361 |
| 162 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.88810400 |
| 163 | Stridor (HP:0010307) | 1.88794240 |
| 164 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88056627 |
| 165 | Abnormality of the thoracic spine (HP:0100711) | 1.88052931 |
| 166 | Xanthomatosis (HP:0000991) | 1.86866990 |
| 167 | Short humerus (HP:0005792) | 1.86131639 |
| 168 | Nausea (HP:0002018) | 1.86084964 |
| 169 | Hypophosphatemia (HP:0002148) | 1.85543292 |
| 170 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85322258 |
| 171 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.85130910 |
| 172 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84777976 |
| 173 | Stroke (HP:0001297) | 1.84416379 |
| 174 | Esophageal varix (HP:0002040) | 1.82185770 |
| 175 | Cellulitis (HP:0100658) | 1.82046364 |
| 176 | Thin bony cortex (HP:0002753) | 1.81846530 |
| 177 | Distal lower limb amyotrophy (HP:0008944) | 1.81798459 |
| 178 | Deformed sella turcica (HP:0002681) | 1.80436540 |
| 179 | Overlapping toe (HP:0001845) | 1.79518690 |
| 180 | Focal motor seizures (HP:0011153) | 1.79070721 |
| 181 | Hematochezia (HP:0002573) | 1.77166952 |
| 182 | Ulnar claw (HP:0001178) | 1.76911157 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.76057524 |
| 184 | Distal lower limb muscle weakness (HP:0009053) | 1.75247258 |
| 185 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74294575 |
| 186 | Radial bowing (HP:0002986) | 1.73457819 |
| 187 | Pustule (HP:0200039) | 1.72015171 |
| 188 | Malnutrition (HP:0004395) | 1.71642764 |
| 189 | Myopathic facies (HP:0002058) | 1.70380914 |
| 190 | Diaphragmatic weakness (HP:0009113) | 1.69929356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.00692504 |
| 2 | LATS1 | 6.66968755 |
| 3 | ERN1 | 5.10566826 |
| 4 | GRK5 | 4.95498428 |
| 5 | GRK6 | 4.37132685 |
| 6 | LATS2 | 4.29999796 |
| 7 | ADRBK2 | 3.65533408 |
| 8 | STK38L | 3.49511849 |
| 9 | CSF1R | 3.45410404 |
| 10 | GRK1 | 2.98668833 |
| 11 | IRAK3 | 2.84389577 |
| 12 | TRIB3 | 2.76072131 |
| 13 | TGFBR2 | 2.68977658 |
| 14 | GRK7 | 2.63135983 |
| 15 | MATK | 2.44945276 |
| 16 | TTK | 2.31262775 |
| 17 | STK38 | 2.23962216 |
| 18 | MAPK7 | 2.14456882 |
| 19 | PRKD3 | 2.14319295 |
| 20 | MST1R | 2.10974967 |
| 21 | STK10 | 2.05811290 |
| 22 | PRPF4B | 1.86718418 |
| 23 | TESK1 | 1.80833804 |
| 24 | MAP2K2 | 1.80049051 |
| 25 | SIK1 | 1.76037729 |
| 26 | MOS | 1.68404739 |
| 27 | SMG1 | 1.67751981 |
| 28 | PDPK1 | 1.65546038 |
| 29 | MAP3K11 | 1.65410158 |
| 30 | TYRO3 | 1.64051249 |
| 31 | ARAF | 1.62605079 |
| 32 | CDK7 | 1.61948934 |
| 33 | RIPK4 | 1.59029792 |
| 34 | WNK1 | 1.56529461 |
| 35 | PRKG2 | 1.49007991 |
| 36 | KSR2 | 1.48253236 |
| 37 | MAP3K2 | 1.45692442 |
| 38 | PAK4 | 1.40376878 |
| 39 | CAMK4 | 1.27052397 |
| 40 | BUB1 | 1.23752552 |
| 41 | TNK2 | 1.19011585 |
| 42 | CHEK2 | 1.17842948 |
| 43 | MAP2K6 | 1.16827809 |
| 44 | MAP3K3 | 1.16022389 |
| 45 | PLK1 | 1.14763503 |
| 46 | ICK | 1.14085385 |
| 47 | NTRK1 | 1.13859230 |
| 48 | MAP3K10 | 1.12529490 |
| 49 | ADRBK1 | 1.11915977 |
| 50 | RIPK1 | 1.08909152 |
| 51 | MAP4K1 | 1.06861517 |
| 52 | MARK2 | 1.05997018 |
| 53 | HIPK2 | 1.02887248 |
| 54 | WEE1 | 1.01287967 |
| 55 | MELK | 1.00330128 |
| 56 | TBK1 | 0.99690611 |
| 57 | MAP3K1 | 0.97988510 |
| 58 | EPHA2 | 0.97660864 |
| 59 | MAP2K4 | 0.96766321 |
| 60 | CCNB1 | 0.95701858 |
| 61 | MAP3K13 | 0.94692993 |
| 62 | ACVR1B | 0.92233637 |
| 63 | STK16 | 0.88290836 |
| 64 | PDK2 | 0.87548754 |
| 65 | ABL2 | 0.85876019 |
| 66 | TESK2 | 0.85465421 |
| 67 | CDC7 | 0.85227997 |
| 68 | SRPK1 | 0.84615690 |
| 69 | IRAK4 | 0.83604595 |
| 70 | KIT | 0.83298173 |
| 71 | NEK2 | 0.83222397 |
| 72 | DYRK3 | 0.82559871 |
| 73 | BLK | 0.81235520 |
| 74 | AKT3 | 0.79469059 |
| 75 | EIF2AK3 | 0.78641930 |
| 76 | EIF2AK2 | 0.78334848 |
| 77 | BCKDK | 0.78117530 |
| 78 | MAP3K8 | 0.76833296 |
| 79 | PRKD2 | 0.74508713 |
| 80 | TAOK1 | 0.72201230 |
| 81 | EIF2AK1 | 0.70580371 |
| 82 | SIK3 | 0.68708723 |
| 83 | CHEK1 | 0.67480494 |
| 84 | FLT3 | 0.67253661 |
| 85 | CDK8 | 0.66040952 |
| 86 | PRKD1 | 0.65821236 |
| 87 | NME2 | 0.65320365 |
| 88 | ZAP70 | 0.65114077 |
| 89 | AKT2 | 0.62135798 |
| 90 | BRAF | 0.60829613 |
| 91 | PDK4 | 0.60154224 |
| 92 | PDK3 | 0.60154224 |
| 93 | MAPK11 | 0.58209065 |
| 94 | FGFR3 | 0.57319492 |
| 95 | MAPK12 | 0.56521319 |
| 96 | EPHB1 | 0.56156117 |
| 97 | MET | 0.55851015 |
| 98 | VRK1 | 0.53182207 |
| 99 | AURKA | 0.52285520 |
| 100 | CSK | 0.51551251 |
| 101 | PDK1 | 0.51078605 |
| 102 | EEF2K | 0.51058974 |
| 103 | ITK | 0.50668220 |
| 104 | AURKB | 0.49985548 |
| 105 | PRKAA2 | 0.48900532 |
| 106 | BMX | 0.48557839 |
| 107 | BRSK2 | 0.47089370 |
| 108 | NLK | 0.46705948 |
| 109 | IRAK2 | 0.46642332 |
| 110 | PTK6 | 0.46514497 |
| 111 | LMTK2 | 0.46272821 |
| 112 | LRRK2 | 0.46142493 |
| 113 | IGF1R | 0.44423694 |
| 114 | MAPK4 | 0.44385972 |
| 115 | CDK4 | 0.43967437 |
| 116 | PRKCD | 0.42926186 |
| 117 | SIK2 | 0.42299733 |
| 118 | WNK3 | 0.41209486 |
| 119 | IKBKB | 0.40734165 |
| 120 | CDK2 | 0.40303215 |
| 121 | PRKCI | 0.40124067 |
| 122 | CDK19 | 0.39928659 |
| 123 | STK3 | 0.39447034 |
| 124 | RPS6KB2 | 0.38773786 |
| 125 | SCYL2 | 0.37711099 |
| 126 | NEK1 | 0.37629139 |
| 127 | TSSK6 | 0.37319141 |
| 128 | JAK3 | 0.36515868 |
| 129 | PIM2 | 0.36353222 |
| 130 | LIMK1 | 0.35924960 |
| 131 | DYRK2 | 0.35440505 |
| 132 | MAPKAPK3 | 0.35345188 |
| 133 | IKBKE | 0.34525628 |
| 134 | PAK1 | 0.34269438 |
| 135 | KDR | 0.34266906 |
| 136 | SYK | 0.33779032 |
| 137 | CSNK1A1L | 0.33456521 |
| 138 | MAP3K7 | 0.33427087 |
| 139 | DAPK1 | 0.32062140 |
| 140 | CDC42BPA | 0.31981850 |
| 141 | BRSK1 | 0.31903538 |
| 142 | ATR | 0.31573956 |
| 143 | MAP2K3 | 0.30196711 |
| 144 | RPS6KA2 | 0.29489730 |
| 145 | NME1 | 0.29456845 |
| 146 | ATM | 0.27429538 |
| 147 | PTK2 | 0.26376749 |
| 148 | VRK2 | 0.26246074 |
| 149 | NEK9 | 0.25299727 |
| 150 | TAOK2 | 0.23269517 |
| 151 | MST4 | 0.21609628 |
| 152 | LCK | 0.21101684 |
| 153 | CDK1 | 0.20909019 |
| 154 | ALK | 0.20033655 |
| 155 | LYN | 0.16881617 |
| 156 | MTOR | 0.16289628 |
| 157 | CSNK2A1 | 0.16053880 |
| 158 | TLK1 | 0.16024733 |
| 159 | TYK2 | 0.14826831 |
| 160 | CSNK2A2 | 0.12027000 |
| 161 | MAPKAPK2 | 0.11965677 |
| 162 | PRKACB | 0.11825619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.88106857 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.22774300 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.36267852 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.92656185 |
| 5 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.66979033 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.25926054 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.24790213 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.88775183 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.87746304 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.52160672 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.37006628 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.26229537 |
| 13 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.19233904 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.16611127 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.13900383 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.09858825 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.98053294 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.95413609 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.86035455 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82692747 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.79524462 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.79253370 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.72849515 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.69732234 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69119362 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61973944 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.59904862 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55473866 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54626606 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.53323262 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45318521 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44283507 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41124794 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40147421 |
| 35 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.39614828 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 1.34216041 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.30884352 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30339498 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30204323 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26294535 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21191334 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20951347 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18952630 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15791012 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.13711765 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11543292 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10393734 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10210027 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09848841 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08378296 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.07975930 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04689993 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03382298 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03372951 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00483214 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99293891 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96505088 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95273487 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94873672 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93944138 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93532535 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93322977 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92645030 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87538775 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86835894 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.84839244 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82093710 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82084126 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.79698776 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78721117 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78022764 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73721220 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.73306780 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71278492 |
| 75 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71113168 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.70295486 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68573012 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67935605 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67083784 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66814929 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65797231 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65254814 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65169828 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65004975 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64227123 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63971613 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63601340 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63535663 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62478774 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61682410 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61422276 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61021826 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.60624456 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59313096 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58538235 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58012645 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.57236247 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54827300 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54066492 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52382687 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51548634 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51452418 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51410191 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51329913 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50558866 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.49342934 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.49098468 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48533510 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46873535 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.46684769 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44952189 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.44823313 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43683642 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43402241 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42844347 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42783828 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41542014 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40936413 |
| 119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40292811 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40026758 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39913252 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.39340275 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38900300 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.38766470 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37920517 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37414318 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36932896 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35570341 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35371816 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33343860 |
| 131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32959915 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.32804460 |
| 133 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31114794 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30943176 |
| 135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30879197 |
| 136 | Peroxisome_Homo sapiens_hsa04146 | 0.30825289 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30562319 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30464019 |
| 139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30050415 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29789803 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29542184 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.28797560 |
| 143 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28473870 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27952424 |
| 145 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27206606 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25080104 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23607134 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23145386 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22508827 |
| 150 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22477601 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20110881 |
| 152 | Legionellosis_Homo sapiens_hsa05134 | 0.19381209 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19287546 |
| 154 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18739728 |
| 155 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.18727571 |
| 156 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17204460 |
| 157 | Apoptosis_Homo sapiens_hsa04210 | 0.15481832 |
| 158 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14893294 |
| 159 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13840655 |
| 160 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.13657720 |
| 161 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.13319156 |
| 162 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.09659181 |

